BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lewis GJ, Massey DC, Zhang H, Bredin F, Tremelling M, Lee JC, Berzuini C, Parkes M. Genetic association between NLRP3 variants and Crohn's disease does not replicate in a large UK panel. Inflamm Bowel Dis. 2011;17:1387-1391. [PMID: 21560198 DOI: 10.1002/ibd.21499] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Kim JM. [Inflammatory bowel diseases and inflammasome]. Korean J Gastroenterol 2011;58:300-10. [PMID: 22198227 DOI: 10.4166/kjg.2011.58.6.300] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
2 Xu Q, Zhou X, Strober W, Mao L. Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease. Molecules 2021;26:1725. [PMID: 33808793 DOI: 10.3390/molecules26061725] [Reference Citation Analysis]
3 Opipari A, Franchi L. Role of Inflammasomes in Intestinal Inflammation and Crohnʼs Disease: . Inflammatory Bowel Diseases 2015;21:173-81. [DOI: 10.1097/mib.0000000000000230] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
4 Ke P, Shao BZ, Xu ZQ, Chen XW, Liu C. Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease. Front Immunol 2016;7:695. [PMID: 28119697 DOI: 10.3389/fimmu.2016.00695] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
5 Zhong Y, Kinio A, Saleh M. Functions of NOD-Like Receptors in Human Diseases. Front Immunol 2013;4:333. [PMID: 24137163 DOI: 10.3389/fimmu.2013.00333] [Cited by in Crossref: 138] [Cited by in F6Publishing: 124] [Article Influence: 15.3] [Reference Citation Analysis]
6 Man SM. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol Hepatol 2018;15:721-37. [PMID: 30185915 DOI: 10.1038/s41575-018-0054-1] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 23.7] [Reference Citation Analysis]
7 Conforti-Andreoni C, Ricciardi-Castagnoli P, Mortellaro A. The inflammasomes in health and disease: from genetics to molecular mechanisms of autoinflammation and beyond. Cell Mol Immunol. 2011;8:135-145. [PMID: 21258359 DOI: 10.1038/cmi.2010.81] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
8 Cambui RAG, do Espírito Santo GF, Fernandes FP, Leal VNC, Galera BB, Fávaro EGP, Rizzo LA, Elias RM, Pontillo A. Double-edged sword of inflammasome genetics in colorectal cancer prognosis. Clin Immunol 2020;213:108373. [PMID: 32135277 DOI: 10.1016/j.clim.2020.108373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Keogh CE, Rude KM, Gareau MG. Role of pattern recognition receptors and the microbiota in neurological disorders. J Physiol 2021;599:1379-89. [PMID: 33404072 DOI: 10.1113/JP279771] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Sester DP, Sagulenko V, Thygesen SJ, Cridland JA, Loi YS, Cridland SO, Masters SL, Genske U, Hornung V, Andoniou CE. Deficient NLRP3 and AIM2 Inflammasome Function in Autoimmune NZB Mice. J Immunol. 2015;195:1233-1241. [PMID: 26116505 DOI: 10.4049/jimmunol.1402859] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
11 Zhen Y, Zhang H. NLRP3 Inflammasome and Inflammatory Bowel Disease. Front Immunol. 2019;10:276. [PMID: 30873162 DOI: 10.3389/fimmu.2019.00276] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 27.0] [Reference Citation Analysis]
12 Davis BK, Philipson C, Hontecillas R, Eden K, Bassaganya-Riera J, Allen IC. Emerging significance of NLRs in inflammatory bowel disease. Inflamm Bowel Dis 2014;20:2412-32. [PMID: 25153506 DOI: 10.1097/MIB.0000000000000151] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
13 Carlström M, Ekman AK, Petersson S, Söderkvist P, Enerbäck C. Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility. Exp Dermatol 2012;21:932-7. [PMID: 23171454 DOI: 10.1111/exd.12049] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 6.7] [Reference Citation Analysis]
14 Bloemendaal AL, Buchs NC, George BD, Guy RJ. Intestinal stem cells and intestinal homeostasis in health and in inflammation: A review. Surgery 2016;159:1237-48. [PMID: 26936524 DOI: 10.1016/j.surg.2016.01.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
15 Tourkochristou E, Aggeletopoulou I, Konstantakis C, Triantos C. Role of NLRP3 inflammasome in inflammatory bowel diseases. World J Gastroenterol 2019;25:4796-804. [PMID: 31543674 DOI: 10.3748/wjg.v25.i33.4796] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
16 Antoni L, Nuding S, Wehkamp J, Stange EF. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2014; 20(5): 1165-1179 [PMID: 24574793 DOI: 10.3748/wjg.v20.i5.1165] [Cited by in CrossRef: 169] [Cited by in F6Publishing: 149] [Article Influence: 21.1] [Reference Citation Analysis]
17 Corridoni D, Chapman T, Ambrose T, Simmons A. Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease. Front Med (Lausanne) 2018;5:32. [PMID: 29515999 DOI: 10.3389/fmed.2018.00032] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
18 Cheng CH, Lee YS, Chang CJ, Lin JC, Lin TY. Genetic Polymorphisms in Inflammasome-Dependent Innate Immunity among Pediatric Patients with Severe Renal Parenchymal Infections. PLoS One 2015;10:e0140128. [PMID: 26444566 DOI: 10.1371/journal.pone.0140128] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
19 Shao BZ, Xu ZQ, Han BZ, Su DF, Liu C. NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol 2015;6:262. [PMID: 26594174 DOI: 10.3389/fphar.2015.00262] [Cited by in Crossref: 284] [Cited by in F6Publishing: 297] [Article Influence: 40.6] [Reference Citation Analysis]
20 Zhang AQ, Zeng L, Gu W, Zhang LY, Zhou J, Jiang DP, Du DY, Hu P, Yang C, Yan J, Wang HY, Jiang JX. Clinical relevance of single nucleotide polymorphisms within the entire NLRP3 gene in patients with major blunt trauma. Crit Care 2011;15:R280. [PMID: 22112657 DOI: 10.1186/cc10564] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
21 Song Y, Zhao Y, Ma Y, Wang Z, Rong L, Wang B, Zhang N. Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease. Cytokine Growth Factor Rev 2021;60:61-75. [PMID: 33773897 DOI: 10.1016/j.cytogfr.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Shi J, Zhang Z, Wu J, Khalaf OI. Research Progress on the Relationship between the NLRP3 Inflammasome and Immune Reconstitution in HIV-Infected Patients Receiving Antiretroviral Therapy. Computational and Mathematical Methods in Medicine 2022;2022:1-5. [DOI: 10.1155/2022/3179200] [Reference Citation Analysis]
23 Wagatsuma K, Nakase H. Contradictory Effects of NLRP3 Inflammasome Regulatory Mechanisms in Colitis. Int J Mol Sci 2020;21:E8145. [PMID: 33143375 DOI: 10.3390/ijms21218145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Irak K, Bayram M, Cifci S, Sener G. Serum levels of NLRC4 and MCP-2/CCL8 in patients with active Crohn's disease. PLoS One 2021;16:e0260034. [PMID: 34788319 DOI: 10.1371/journal.pone.0260034] [Reference Citation Analysis]
25 Aguilera M, Darby T, Melgar S. The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases - lessons learned from experimental models. Cytokine Growth Factor Rev. 2014;25:715-730. [PMID: 24803013 DOI: 10.1016/j.cytogfr.2014.04.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
26 Santaolalla R, Fukata M, Abreu MT. Innate immunity in the small intestine. Curr Opin Gastroenterol. 2011;27:125-131. [PMID: 21248635 DOI: 10.1097/mog.0b013e3283438dea] [Cited by in Crossref: 64] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
27 Elia PP, Tolentino YF, Bernardazzi C, de Souza HS. The role of innate immunity receptors in the pathogenesis of inflammatory bowel disease. Mediators Inflamm 2015;2015:936193. [PMID: 25821356 DOI: 10.1155/2015/936193] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
28 Levy M, Thaiss CA, Katz MN, Suez J, Elinav E. Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis. Semin Immunopathol 2015;37:39-46. [PMID: 25315349 DOI: 10.1007/s00281-014-0451-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
29 Elinav E, Henao-Mejia J, Flavell RA. Integrative inflammasome activity in the regulation of intestinal mucosal immune responses. Mucosal Immunol 2013;6:4-13. [PMID: 23212196 DOI: 10.1038/mi.2012.115] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
30 Zambetti LP, Mortellaro A. NLRPs, microbiota, and gut homeostasis: unravelling the connection. J Pathol 2014;233:321-30. [PMID: 24740681 DOI: 10.1002/path.4357] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
31 Shao BZ, Cao Q, Liu C. Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases. Front Mol Neurosci 2018;11:320. [PMID: 30233319 DOI: 10.3389/fnmol.2018.00320] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
32 Mao L, Kitani A, Similuk M, Oler AJ, Albenberg L, Kelsen J, Aktay A, Quezado M, Yao M, Montgomery-Recht K, Fuss IJ, Strober W. Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn's disease. J Clin Invest. 2018;128:1793-1806. [PMID: 29408806 DOI: 10.1172/jci98642] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
33 Yao X, Meng G. Inflammasomes in the Gut Mucosal Homeostasis. Adv Exp Med Biol 2017;1024:133-51. [PMID: 28921468 DOI: 10.1007/978-981-10-5987-2_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 de Zoete MR, Flavell RA. Interactions between Nod-Like Receptors and Intestinal Bacteria. Front Immunol. 2013;4:462. [PMID: 24381573 DOI: 10.3389/fimmu.2013.00462] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
35 Shao BZ, Wang SL, Pan P, Yao J, Wu K, Li ZS, Bai Y, Linghu EQ. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation. Inflammation. 2019;42:1147-1159. [PMID: 30937839 DOI: 10.1007/s10753-019-01008-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
36 Hanaei S, Sadr M, Rezaei A, Shahkarami S, Ebrahimi Daryani N, Bidoki AZ, Rezaei N. Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study. Clin Res Hepatol Gastroenterol 2018;42:269-75. [PMID: 29102545 DOI: 10.1016/j.clinre.2017.09.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
37 Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol. 2011;8:152-168. [PMID: 21304476 DOI: 10.1038/nrgastro.2011.3] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 9.0] [Reference Citation Analysis]
38 Yue C, Yang X, Li J, Chen X, Zhao X, Chen Y, Wen Y. Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagy in colonic epithelial cells. Biochem Biophys Res Commun 2017;490:541-51. [PMID: 28629999 DOI: 10.1016/j.bbrc.2017.06.075] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
39 Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, Yue Y, Qian W, Li L. NLRP3 Inflammasome and Inflammatory Diseases. Oxid Med Cell Longev. 2020;2020:4063562. [PMID: 32148650 DOI: 10.1155/2020/4063562] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
40 Paramel GV, Sirsjö A, Fransén K. Role of genetic alterations in the NLRP3 and CARD8 genes in health and disease. Mediators Inflamm 2015;2015:846782. [PMID: 25788762 DOI: 10.1155/2015/846782] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
41 Chen GY, Núñez G. Inflammasomes in Intestinal Inflammation and Cancer. Gastroenterology 2011;141:1986-99. [DOI: 10.1053/j.gastro.2011.10.002] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 9.5] [Reference Citation Analysis]
42 Choy MC, Visvanathan K, De Cruz P. An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2017;23:2-13. [DOI: 10.1097/mib.0000000000000955] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
43 Vanhove W, Peeters PM, Staelens D, Schraenen A, Van der Goten J, Cleynen I, De Schepper S, Van Lommel L, Reynaert NL, Schuit F, Van Assche G, Ferrante M, De Hertogh G, Wouters EF, Rutgeerts P, Vermeire S, Nys K, Arijs I. Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:2673-82. [PMID: 26313692 DOI: 10.1097/MIB.0000000000000535] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
44 Rathinam VAK, Chan FK. Inflammasome, Inflammation, and Tissue Homeostasis. Trends Mol Med 2018;24:304-18. [PMID: 29433944 DOI: 10.1016/j.molmed.2018.01.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 11.3] [Reference Citation Analysis]
45 Keshavarz Shahbaz S, Koushki K, Ayati SH, Bland AR, Bezsonov EE, Sahebkar A. Inflammasomes and Colorectal Cancer. Cells 2021;10:2172. [PMID: 34571825 DOI: 10.3390/cells10092172] [Reference Citation Analysis]
46 Paramel Varghese G, Folkersen L, Strawbridge RJ, Halvorsen B, Yndestad A, Ranheim T, Krohg-Sørensen K, Skjelland M, Espevik T, Aukrust P, Lengquist M, Hedin U, Jansson JH, Fransén K, Hansson GK, Eriksson P, Sirsjö A. NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis. J Am Heart Assoc 2016;5:e003031. [PMID: 27207962 DOI: 10.1161/JAHA.115.003031] [Cited by in Crossref: 102] [Cited by in F6Publishing: 64] [Article Influence: 17.0] [Reference Citation Analysis]
47 Rubino SJ, Selvanantham T, Girardin SE, Philpott DJ. Nod-like receptors in the control of intestinal inflammation. Curr Opin Immunol. 2012;24:398-404. [PMID: 22677577 DOI: 10.1016/j.coi.2012.04.010] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 5.5] [Reference Citation Analysis]
48 Nunes T, de Souza HS. Inflammasome in intestinal inflammation and cancer. Mediators Inflamm 2013;2013:654963. [PMID: 23606794 DOI: 10.1155/2013/654963] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
49 Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol. 2011;8:152-168. [PMID: 21304476 DOI: 10.1038/nrgastro.2011.56.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Yang CA, Huang ST, Chiang BL. Association of NLRP3 and CARD8 genetic polymorphisms with juvenile idiopathic arthritis in a Taiwanese population. Scand J Rheumatol 2014;43:146-52. [PMID: 24295199 DOI: 10.3109/03009742.2013.834962] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
51 Zhang HX, Wang ZT, Lu XX, Wang YG, Zhong J, Liu J. NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn's disease (CD), in Chinese Han population. Inflamm Res. 2014;63:979-985. [PMID: 25297810 DOI: 10.1007/s00011-014-0774-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
52 Lazaridis LD, Pistiki A, Giamarellos-Bourboulis EJ, Georgitsi M, Damoraki G, Polymeros D, Dimitriadis GD, Triantafyllou K. Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis. Dig Dis Sci. 2017;62:2348-2356. [PMID: 28523573 DOI: 10.1007/s10620-017-4609-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 9.8] [Reference Citation Analysis]